1. Home
  2. DHX vs IPHA Comparison

DHX vs IPHA Comparison

Compare DHX & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$4.59

Market Cap

178.0M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.92

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
IPHA
Founded
1991
1999
Country
United States
France
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.0M
165.3M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
DHX
IPHA
Price
$4.59
$1.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$6.25
$5.75
AVG Volume (30 Days)
273.1K
52.7K
Earning Date
05-05-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$127,826,000.00
N/A
Revenue This Year
N/A
$180.36
Revenue Next Year
$3.52
N/A
P/E Ratio
$45.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$1.18
52 Week High
$4.79
$2.71

Technical Indicators

Market Signals
Indicator
DHX
IPHA
Relative Strength Index (RSI) 54.91 41.28
Support Level $3.80 $1.67
Resistance Level N/A $1.95
Average True Range (ATR) 0.28 0.08
MACD 0.01 -0.05
Stochastic Oscillator 60.23 0.00

Price Performance

Historical Comparison
DHX
IPHA

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: